Application Nr Approved Date Route Status External Links
BLA125476 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Entyvio Is Indicated In Adults For The Treatment Of: Moderately To Severely Active Ulcerative Colitis. Moderately To Severely Active Crohn's Disease. Entyvio Is An Integrin Receptor Antagonist Indicated In Adults For The Treatment Of: Moderately To Severely Active Ulcerative Colitis. ( 1 ) Moderately To Severely Active Crohn's Disease. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Vedolizumab

Comments